US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tempus AI

61.37

-3.8500-5.90%

Post-market: 61.08-0.2892-0.47%19:59 EDT

Volume:15.52M

Turnover:977.93M

Market Cap:10.62B

PE:-12.47

High:66.30

Open:66.26

Low:60.50

Close:65.22

Loading ...

Overview Company News Filings

Tempus AI Price Target Maintained With a $56.00/Share by Needham

Cathie Wood's ARK Snaps Up Tempus AI Shares Despite Revenue Miss and Market Sell-Off

Cathie Wood’s ARKG Loads Up on Tempus AI (NASDAQ:TEM) as Stock Plunges on Revenue Miss

Here’s Why Tempus AI, Inc (TEM) Is Among Monday’s Top Losers

Cathie Wood’s ARK Investment bought 379K shares of Tempus AI today

Stock Track | Tempus AI Soars 6.65% on xH Whole-Genome Sequencing Announcement Despite Growth Concerns

Sector Update: Tech Stocks Decline Late Afternoon

MT Newswires Live

Tempus AI Reports Preliminary 2024 Revenue of $693 Million, Shares Fall Over 14%

Tempus AI: Balancing Promising Growth with Current Performance Shortfalls

Tempus AI Preliminary Q4, 2024 Revenue Misses Estimates; Shares Fall

MT Newswires Live

Tempus AI Shares Fall 11.7% After 4Q Revenue Projections Fall Below Expectations

Stock Track | Tempus AI Plummets 11.91% on CRO Revenue Softness Despite Overall Growth

Tempus Announces Its First-Ever, Whole-Genome Sequencing Assay, xH

Tempus AI Shares Down 4.7% Premarket After Co Announces Preliminary Q4 Results

THOMSON REUTERS

Tempus AI Inc - Q4 2024 Revenue Approximately $200 Million, 35% Growth YoY

THOMSON REUTERS

Tempus AI Inc - Sequential Improvement in Adjusted Ebitda in Q4 2024

THOMSON REUTERS

Stock Track | Tempus AI Sinks 5.36% in Pre-Market as Preliminary Results Show CRO Revenue Softness

Tempus AI Stock Falls Despite Collaboration Announcement With Genialis

Tempus, Genialis Collaborate to Advance RNA-Based Biomarker Algorithms for Cancer Treatment

MT Newswires Live

Tempus AI teams with Genialis to develop RNA-based biomarker algorithms

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TEM/news?page=16"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TEM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TEM\",,,,,undefined,":{"symbol":"TEM","market":"US","secType":"STK","nameCN":"Tempus AI","latestPrice":61.37,"timestamp":1746820800000,"preClose":65.22,"halted":0,"volume":15516405,"hourTrading":{"tag":"盘后","latestPrice":61.0808,"preClose":61.37,"latestTime":"19:59 EDT","volume":109308,"amount":6699798.9006,"timestamp":1746835196621},"delay":0,"floatShares":100646651,"shares":173116245,"eps":-4.919661,"marketStatus":"Market Closed","change":-3.85,"latestTime":"05-09 16:00:00 EDT","open":66.26,"high":66.2999,"low":60.5,"amount":977933527.9209,"amplitude":0.088928,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.919661,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"listingDate":1718337600000,"exchange":"NASDAQ","adjPreClose":65.22,"preHourTrading":{"tag":"盘前","latestPrice":66.21,"preClose":65.22,"latestTime":"09:29 EDT","volume":331783,"amount":22012000.46831,"timestamp":1746797399999},"postHourTrading":{"tag":"盘后","latestPrice":61.0808,"preClose":61.37,"latestTime":"19:59 EDT","volume":109308,"amount":6699798.9006,"timestamp":1746835196621},"volumeRatio":0.8783447101692402,"impliedVol":0.8369,"impliedVolPercentile":0.0811},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TEM\",,,,,undefined,":{"symbol":"TEM","floatShares":100646651,"roa":"-43.89%","roe":"--","lyrEps":-6.227252,"volumeRatio":0.8783447101692402,"shares":173116245,"dividePrice":0,"high":66.2999,"amplitude":0.088928,"preClose":65.22,"low":60.5,"week52Low":22.89,"pbRate":"32.57","psRate":"13.23","week52High":91.45,"institutionHeld":0,"latestPrice":61.37,"eps":-4.919661,"divideRate":0,"volume":15516405,"delay":0,"ttmEps":-4.919661,"open":66.26,"prevYearClose":33.76,"prevWeekClose":57.06,"prevMonthClose":51.67,"prevQuarterClose":48.24,"fiveDayClose":57.06,"twentyDayClose":40.29,"sixtyDayClose":73.88},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TEM\",pageSize:20,pageCount:16,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2503152932","title":"Tempus AI Price Target Maintained With a $56.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2503152932","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503152932?lang=en_us&edition=fundamental","pubTime":"2025-01-14 19:51","pubTimestamp":1736855460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TEM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 14, 2025 06:51 ET (11:51 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"gpt_icon":0},{"id":"2503284165","title":"Cathie Wood's ARK Snaps Up Tempus AI Shares Despite Revenue Miss and Market Sell-Off","url":"https://stock-news.laohu8.com/highlight/detail?id=2503284165","media":"GuruFocus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503284165?lang=en_us&edition=fundamental","pubTime":"2025-01-14 18:46","pubTimestamp":1736851591,"startTime":"0","endTime":"0","summary":"Cathie Wood's ARK Investment Management adds to its stake in Tempus AI  after the stock tumbled nearly 14% on Monday, January 13 4:00 PM ET. The company announces preliminary fourth-quarter revenue projections that fall short of expectations, shaking investor confidence.Tempus AI predicts $200 million in revenue for the quarter, missing analysts' estimates of $205.7 million. Even so, the number shows a 35% jump from the same period last year. CEO Eric Lefkofsky highlights strong growth in genomics revenue, up 30%, and data and services revenue, which climbs 45%. For the full year, revenue climbs 30% to approximately $693 million.ARK's Genomic Revolution ETF  snaps up 379,000 shares during the sell-off, bringing its total holding in Tempus AI to over $47 million. The position now accounts for 4.08% of the fund's portfolio. Other top names in the fund include Twist Bioscience , Recursion Pharmaceuticals , and Crispr Therapeutics .The purchase shows ARK's confidence in Tempus AI's potenti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2655447/cathie-woods-ark-snaps-up-tempus-ai-shares-despite-revenue-miss-and-market-selloff","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["TEM","ARKK"],"gpt_icon":1},{"id":"2503427135","title":"Cathie Wood’s ARKG Loads Up on Tempus AI (NASDAQ:TEM) as Stock Plunges on Revenue Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2503427135","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503427135?lang=en_us&edition=fundamental","pubTime":"2025-01-14 18:02","pubTimestamp":1736848945,"startTime":"0","endTime":"0","summary":"Cathie Wood’s ARK Investment loaded up on more shares of medical technology business Tempus AI ($TEM) on Monday, January 13th, as the stock took a ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/cathie-woods-arkg-loads-up-on-tempus-ai-nasdaqtem-as-stock-plunges-on-revenue-miss?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/cathie-woods-arkg-loads-up-on-tempus-ai-nasdaqtem-as-stock-plunges-on-revenue-miss?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEM",".IXIC","NDAQ","ARKG","ARKK","NQmain"],"gpt_icon":0},{"id":"2503516572","title":"Here’s Why Tempus AI, Inc (TEM) Is Among Monday’s Top Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2503516572","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503516572?lang=en_us&edition=fundamental","pubTime":"2025-01-14 13:57","pubTimestamp":1736834262,"startTime":"0","endTime":"0","summary":"Ten companies—mostly under the quantum computing sector—kicked off the trading week leading declines amid not-so-optimistic statements from chief executives and disappointing earnings updates that have weighed in on investor sentiment.Meanwhile, Wall Street's main indices ended mixed, with the Dow Jones and S&P’s main index the only gainers, up 0.86 percent and 0.16 percent, respectively. Meanwhile, the Nasdaq Composite dropped by 0.38 percent.To come up with Monday’s top losers, we considered only the stocks with at least $2 billion in market capitalization and $5 million in daily trading volume.A healthcare professional wearing a health communications device discussing patient data with a colleague.Tempus AI, Inc  fell by 13.81 percent on Monday to end at $32.34 each after fourth-quarter forecasts fell below Wall Street expectations.Tempus AI CEO Eric Lefkofsky said that genomics revenue is expected to rise by 30% in the fourth quarter, while data and services revenue is expected to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-tempus-ai-inc-tem-055742877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","USAW.SI","BK4121","TQQQ","USJW.SI","QID","SQQQ","QLD","NVIW.SI","NQmain","TEM","MNQmain","TSYW.SI",".IXIC"],"gpt_icon":1},{"id":"2503561186","title":"Cathie Wood’s ARK Investment bought 379K shares of Tempus AI today","url":"https://stock-news.laohu8.com/highlight/detail?id=2503561186","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503561186?lang=en_us&edition=fundamental","pubTime":"2025-01-14 09:16","pubTimestamp":1736817382,"startTime":"0","endTime":"0","summary":"20:11 EST Cathie Wood’s ARK Investment bought 379K shares of Tempus AI (TEM) today Published first on TheFly – the ultimate source for real-time, m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-bought-379k-shares-of-tempus-ai-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-bought-379k-shares-of-tempus-ai-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKK","BK4585","BK4121","TEM","BK4588","BK4544"],"gpt_icon":0},{"id":"1195585026","title":"Stock Track | Tempus AI Soars 6.65% on xH Whole-Genome Sequencing Announcement Despite Growth Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1195585026","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195585026?lang=en_us&edition=fundamental","pubTime":"2025-01-14 09:04","pubTimestamp":1736816670,"startTime":"0","endTime":"0","summary":"Shares of Tempus AI  skyrocketed 6.65% in Monday's trading session, fueled by the company's announcement of its first whole-genome sequencing test, xH, aimed at advancing personalized cancer treatment and precision medicine.The Chicago-based AI healthcare technology firm revealed that xH, which is currently available for research use only, will facilitate comprehensive genomic profiling and detection of clinically-relevant variants across hematological cancers like leukemia and lymphoma. With pl","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TEM"],"gpt_icon":0},{"id":"2503855353","title":"Sector Update: Tech Stocks Decline Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2503855353","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503855353?lang=en_us&edition=fundamental","pubTime":"2025-01-14 04:58","pubTimestamp":1736801884,"startTime":"0","endTime":"0","summary":"Tech stocks were falling late Monday afternoon with the Technology Select Sector SPDR Fund (XLK) down 1% and the SPDR S&P Semiconductor ETF (XSD) dropping 1.2%.The Philadelphia Semiconductor index she","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0719512351.SGD","LU2097344357.USD","TEM","IE00BKVL7J92.USD","BK4512","LU0788109477.HKD","LU1066051498.USD","SG9999015945.SGD","BK4575","LU2236285917.USD","TEM.AU","LU1989771016.USD","LU1366333091.USD","LU0494093205.USD","LU0314104364.USD","IE00BFSS8Q28.SGD","LU1496350171.SGD","LU1823568750.SGD","LU2065731478.USD","MACW.SI","LU0096362180.USD","LU2133065610.SGD","LU0056508442.USD","LZ","LU2023250504.SGD","AAPL","LU0683600562.USD","LU2462157665.USD","BK4592","LU0949170772.SGD","LU2247934214.USD","LU2505996681.GBP","LU1066051225.USD","XLK","LU1244550221.USD","LU2092627202.USD","XSD","BK4551","CWAN","LU1803068979.SGD","SG9999014542.SGD","LU1720051017.SGD","LU2592432038.USD","ENFN","LU2023250843.SGD","LU2065171311.SGD","LU0661504455.SGD","LU1791710400.SGD","LU1206712785.SGD","LU2552382215.SGD"],"gpt_icon":1},{"id":"2503553778","title":"Tempus AI Reports Preliminary 2024 Revenue of $693 Million, Shares Fall Over 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503553778","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503553778?lang=en_us&edition=fundamental","pubTime":"2025-01-14 04:43","pubTimestamp":1736801021,"startTime":"0","endTime":"0","summary":"Tempus AI  announced preliminary, unaudited financial results for 2024, reporting annual revenue of $693 million, a 30% year-over-year increase, and fourth-quarter revenue of $200 million, up 35%. Shares of Tempus fell 14.1% to $32.24 by 3:36 p.m. EST Monday, a $5.28 drop from the previous close.While fourth-quarter income hit $200 million, showing 35% growth, the business said that yearly sales reached around $693 million, a 30% year-over-year rise.Despite softness in the contract research organization revenues, core businesses gained momentum throughout the year, Tempus founder and CEO Eric Lefkofsky said in the statement.Tempus underlined that although the firm finishes its year-end financial assessment, the numbers are just preliminary and unaudited; they will inevitably alter. During its first earnings call of 2025, the business intends to finish and present these findings.The company's announcement also contained information on its planned Ambry Genetics purchase. According to th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tempus-ai-reports-preliminary-2024-204341107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TEM"],"gpt_icon":1},{"id":"2503390553","title":"Tempus AI: Balancing Promising Growth with Current Performance Shortfalls","url":"https://stock-news.laohu8.com/highlight/detail?id=2503390553","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503390553?lang=en_us&edition=fundamental","pubTime":"2025-01-14 04:37","pubTimestamp":1736800645,"startTime":"0","endTime":"0","summary":"In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on Tempus AI, Inc. Class A (TEM – Research Repo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/tempus-ai-balancing-promising-growth-with-current-performance-shortfalls?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/tempus-ai-balancing-promising-growth-with-current-performance-shortfalls?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0306807586.USD","LU1894683348.USD","LU0234572021.USD","LU0648001328.SGD","LU0052756011.USD","LU0128525689.USD","LU0980610538.SGD","LU1201861165.SGD","BK4207","LU0320765489.SGD","LU1267930227.SGD","LU1201861249.SGD","IE00BKVL7J92.USD","BK4504","LU0971096721.USD","LU1363072403.SGD","IE00BLSP4452.SGD","LU1366192091.USD","LU0477156797.USD","LU0149725797.USD","LU0208291251.USD","LU0130103400.USD","LU1718418525.SGD","LU0640476718.USD","LU1162221912.USD","IE0002270589.USD","BK4585","BAC","IE00BBT3K403.USD","LU1880398471.USD","LU1883839398.USD","BK4588","LU0868494617.USD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU0098860793.USD","TEM","BK4121","IE00BLSP4239.USD","LU0321505868.SGD","LU0320765646.SGD","LU1668664300.SGD","LU0106831901.USD","LU0321505439.SGD","LU0306806265.USD","LU2129689431.USD","LU0070302665.USD","LU1894683264.USD","LU1280957306.USD","BK4534"],"gpt_icon":0},{"id":"2503613533","title":"Tempus AI Preliminary Q4, 2024 Revenue Misses Estimates; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2503613533","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503613533?lang=en_us&edition=fundamental","pubTime":"2025-01-14 01:21","pubTimestamp":1736788898,"startTime":"0","endTime":"0","summary":"Tempus AI  said Monday that it expects Q4 revenue to increase about 35% year on year to approximately $200 million.Analysts polled by FactSet expect $205.7 million.The company reported preliminary 2024 revenue of about $693 million, compared with its previous forecast of about $700 million.Analysts polled by FactSet expect $698.6 million.Shares of Tempus AI were down more than 13% in recent trading.Price: 32.45, Change: -5.07, Percent Change: -13.51","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TEM"],"gpt_icon":1},{"id":"2503867575","title":"Tempus AI Shares Fall 11.7% After 4Q Revenue Projections Fall Below Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2503867575","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503867575?lang=en_us&edition=fundamental","pubTime":"2025-01-13 23:17","pubTimestamp":1736781420,"startTime":"0","endTime":"0","summary":"Tempus AI shares sank Monday after the company forecast fourth-quarter sales below Wall Street expectations.Shares of the Chicago-based artificial intelligence company were recently down 11.7% to $33.14. The stock peaked at $79.49 in June shortly after its initial public offering and hit a low of $22.89 in November.In preliminary results released Monday, the company said it expected revenue for the fourth quarter around $200 million, an increase of around 35% year-over-year. Analysts on Wall Street surveyed by FactSet expected revenue of $205.7 million.Chief Executive Eric Lefkofsky said that genomics revenue is expected to grow 30% in the fourth quarter, while data and services revenue is expected to be up 45%.Tempus is an AI company focused on medicine and healthcare. The company on Monday also said it was developing its first whole-genome sequencing test.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"gpt_icon":1},{"id":"1169413202","title":"Stock Track | Tempus AI Plummets 11.91% on CRO Revenue Softness Despite Overall Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1169413202","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169413202?lang=en_us&edition=fundamental","pubTime":"2025-01-13 22:35","pubTimestamp":1736778906,"startTime":"0","endTime":"0","summary":"Shares of Tempus AI , a leading precision medicine and AI technology company, plummeted 11.91% intraday on Monday, following the company's announcement of preliminary, unaudited financial results for the fourth quarter and full year 2024.While Tempus AI reported an expected revenue growth of around 30% year-over-year to approximately $693 million for the full year 2024 and a 35% increase in Q4 2024 revenue to around $200 million, the company acknowledged softness in its contract research organiz","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TEM"],"gpt_icon":0},{"id":"2503300622","title":"Tempus Announces Its First-Ever, Whole-Genome Sequencing Assay, xH","url":"https://stock-news.laohu8.com/highlight/detail?id=2503300622","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503300622?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:30","pubTimestamp":1736775000,"startTime":"0","endTime":"0","summary":"CHICAGO, January 13, 2025----Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the company is developing its first whole-genome sequencing test, xH. This test marks Tempus’ first foray into adopting whole-genome sequencing  as a platform, supporting clinicians with detection of all clinically-relevant variants and advancing the landscape of personalized therapy, specifically in hematological oncology.About TempusTempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tempus-announces-first-ever-whole-133000325.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4196","TEM","BK4121","WGS"],"gpt_icon":1},{"id":"2503353301","title":"Tempus AI Shares Down 4.7% Premarket After Co Announces Preliminary Q4 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2503353301","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503353301?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:14","pubTimestamp":1736774043,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nL4N3O913Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEM","BK4121"],"gpt_icon":0},{"id":"2503309056","title":"Tempus AI Inc - Q4 2024 Revenue Approximately $200 Million, 35% Growth YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2503309056","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503309056?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:11","pubTimestamp":1736773863,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O90QL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","TEM"],"gpt_icon":0},{"id":"2503309055","title":"Tempus AI Inc - Sequential Improvement in Adjusted Ebitda in Q4 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2503309055","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503309055?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:11","pubTimestamp":1736773863,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O90QL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","TEM"],"gpt_icon":0},{"id":"1158779546","title":"Stock Track | Tempus AI Sinks 5.36% in Pre-Market as Preliminary Results Show CRO Revenue Softness","url":"https://stock-news.laohu8.com/highlight/detail?id=1158779546","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158779546?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:06","pubTimestamp":1736773582,"startTime":"0","endTime":"0","summary":"Tempus AI, a precision medicine and AI technology company, saw its stock plunge 5.36% in pre-market trading on Monday. This decline followed the company's announcement of preliminary unaudited financial results for the fourth quarter and full year 2024.While Tempus reported an expected revenue growth of around 30% year-over-year to approximately $693 million for the full year 2024 and a 35% increase in Q4 2024 revenue to around $200 million, the company acknowledged softness in its contract rese","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Tempus AI Sinks 5.36% in Pre-Market as Preliminary Results Show CRO Revenue Softness","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TEM"],"gpt_icon":1},{"id":"2502460330","title":"Tempus AI Stock Falls Despite Collaboration Announcement With Genialis","url":"https://stock-news.laohu8.com/highlight/detail?id=2502460330","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502460330?lang=en_us&edition=fundamental","pubTime":"2025-01-09 21:36","pubTimestamp":1736429760,"startTime":"0","endTime":"0","summary":"Tempus AI, Inc. TEM recently announced a collaboration with Genialis, the RNA-biomarker company. The multi-year agreement allows Genialis to leverage Tempus’ multimodal dataset to develop new RNA-based algorithms across cancer types.The collaboration between Tempus and Genialis is likely to prove beneficial by combining the former’s expertise in clinical and molecular data with the latter’s AI-driven analytics. Together, they aim to develop advanced RNA-based biomarker algorithms, which can improve the accuracy of diagnostics and the effectiveness of personalized treatments in precision medicine.(Read more: Tempus AI Stock Surges 23% in 6 Months: Should You Snap It Up Now?Tempus' multimodal dataset has played a key role in the development of Genialis krasID, the first commercially available algorithm that identifies which cancer patients will benefit from KRAS inhibition. This algorithm, introduced at the 6th Annual Targeting-RAS Drug Developm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tempus-ai-stock-falls-despite-133600824.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4592","LU0240878834.USD","IE00BJT1NW94.SGD","LU0868494617.USD","LU2237957811.SGD","IE00BFTCPJ56.SGD","LU2720916845.USD","LU1989763690.USD","SGXZ23171101.USD","ARAY","SG9999004303.SGD","BK4121","IE00B4R5TH58.HKD","LU1057294990.SGD","LU2468319806.SGD","BK4585","BK4581","SG9999002232.USD","BK4588","LU0170899867.USD","MASI","LU1023059063.AUD","BK4568","BK4566","LU0266013472.USD","LU2089984988.USD","BK4533","LU1691799644.USD","LU2764263039.SGD","LU1721429741.USD","ABT","BK4082","LU0240877869.USD","LU0205193047.USD","LU2237957902.USD","IE0009355771.USD","LU0234572021.USD","LU2112291526.USD","SG9999002224.SGD","IE0002141913.USD","LU1989763427.SGD","LU1914381329.SGD","LU1061106388.HKD","LU0205194284.USD","LU1721429402.USD","BK4504","TEM","LU2764263203.CNY","IE00BJJMRZ35.SGD","LU2764262908.HKD"],"gpt_icon":1},{"id":"2502705841","title":"Tempus, Genialis Collaborate to Advance RNA-Based Biomarker Algorithms for Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2502705841","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502705841?lang=en_us&edition=fundamental","pubTime":"2025-01-09 01:42","pubTimestamp":1736358137,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) said Wednesday it entered a multi-year collaboration with Genialis to advance the development and validation of RNA-based biomarker algorithms for cancer treatment.Financial details we","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4121","RNA","TEM","TEM.AU","BK7095"],"gpt_icon":1},{"id":"2501727055","title":"Tempus AI teams with Genialis to develop RNA-based biomarker algorithms","url":"https://stock-news.laohu8.com/highlight/detail?id=2501727055","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501727055?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:46","pubTimestamp":1736343987,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM), announced a collaboration with Genialis, the RNA-biomarker company. The multi-year agreement allows Genialis to leverage Tempus’ m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-teams-with-genialis-to-develop-rna-based-biomarker-algorithms?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-teams-with-genialis-to-develop-rna-based-biomarker-algorithms?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4505","BK4139","TEM","RNA","BK4121","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":16,"totalSize":395,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TEM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-06","symbol":"TEM","fiscalQuarterEnding":"2025/03","expectedEps":-0.47,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2025-02-24","symbol":"TEM","fiscalQuarterEnding":"2024/12","expectedEps":-0.31,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740373200000,"reportTimeType":"post","actualEps":-0.33},{"market":"US","date":"2025-01-13","symbol":"TEM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-04","symbol":"TEM","fiscalQuarterEnding":"2024/09","expectedEps":-0.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730696400000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2024-08-06","symbol":"TEM","fiscalQuarterEnding":"2024/06","expectedEps":-4.41,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"post","actualEps":-6.77}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TEM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TEM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.3333,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":12,"updateTime":1745294400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TEM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TEM","date":"2025-05-09","current":-15.922428,"percent":0.125604,"low":-29.603208,"twenty":-14.16984,"median":-11.47731,"eighty":-9.782784,"high":-6.742425,"avg":-12.657354,"sd":4.778628,"marketCap":11290641498},"quantilePoints":[{"date":"2024-06-12","current":-27.212887,"twenty":-27.212887,"median":-27.212887,"eighty":-27.212887,"marketCap":6108857694},{"date":"2024-06-21","current":-20.01629,"twenty":-27.939544,"median":-24.550473,"eighty":-21.368822,"marketCap":4493336948},{"date":"2024-06-28","current":-22.637646,"twenty":-27.212887,"median":-24.73404,"eighty":-22.27051,"marketCap":5081789366},{"date":"2024-07-05","current":-25.251659,"twenty":-26.906925,"median":-25.251659,"eighty":-22.564219,"marketCap":5668593457},{"date":"2024-07-12","current":-27.535249,"twenty":-26.906925,"median":-25.251659,"eighty":-22.667017,"marketCap":6181222875},{"date":"2024-07-15","current":-29.194707,"twenty":-27.212887,"median":-25.292044,"eighty":-22.67436,"marketCap":6553744573},{"date":"2024-08-02","current":-28.842256,"twenty":-27.470777,"median":-25.332429,"eighty":-23.015063,"marketCap":6474624920},{"date":"2024-08-09","current":-8.901726,"twenty":-27.958191,"median":-25.292044,"eighty":-22.343937,"marketCap":6416933507},{"date":"2024-08-16","current":-10.104324,"twenty":-27.470777,"median":-24.480672,"eighty":-9.206046,"marketCap":7283843206},{"date":"2024-08-23","current":-13.814237,"twenty":-27.136397,"median":-22.656003,"eighty":-9.456881,"marketCap":9958186485},{"date":"2024-08-30","current":-12.397063,"twenty":-26.604261,"median":-20.01629,"eighty":-10.261883,"marketCap":8936596611},{"date":"2024-09-06","current":-11.908973,"twenty":-25.699566,"median":-14.657692,"eighty":-10.892118,"marketCap":8584749948},{"date":"2024-09-13","current":-9.729693,"twenty":-25.699566,"median":-13.383947,"eighty":-9.952331,"marketCap":7013785460},{"date":"2024-09-20","current":-10.722999,"twenty":-25.332429,"median":-12.679642,"eighty":-10.104324,"marketCap":7729824284},{"date":"2024-09-27","current":-11.104052,"twenty":-25.251659,"median":-12.364952,"eighty":-10.119309,"marketCap":8004511591},{"date":"2024-10-04","current":-10.481095,"twenty":-25.251659,"median":-11.908973,"eighty":-10.481095,"marketCap":7555444139},{"date":"2024-10-11","current":-9.843153,"twenty":-24.480672,"median":-11.677772,"eighty":-10.292709,"marketCap":7095574377},{"date":"2024-10-18","current":-10.277724,"twenty":-24.377874,"median":-11.503302,"eighty":-10.277724,"marketCap":7408841363},{"date":"2024-10-25","current":-9.89239,"twenty":-22.67436,"median":-11.242131,"eighty":-10.104324,"marketCap":7131067681},{"date":"2024-10-31","current":-9.742538,"twenty":-22.644989,"median":-11.044111,"eighty":-9.940343,"marketCap":7023044583},{"date":"2024-11-08","current":-12.029604,"twenty":-22.343937,"median":-10.984171,"eighty":-9.885968,"marketCap":8941340337},{"date":"2024-11-15","current":-11.995712,"twenty":-20.467134,"median":-11.242131,"eighty":-9.940343,"marketCap":8916149028},{"date":"2024-11-22","current":-11.116634,"twenty":-17.156812,"median":-11.333112,"eighty":-9.959181,"marketCap":8262749443},{"date":"2024-11-29","current":-13.258196,"twenty":-15.952624,"median":-11.432255,"eighty":-9.973738,"marketCap":9854525298},{"date":"2024-12-06","current":-11.260676,"twenty":-15.430514,"median":-11.47731,"eighty":-10.055515,"marketCap":8369812508},{"date":"2024-12-13","current":-8.894578,"twenty":-14.914582,"median":-11.360942,"eighty":-9.928355,"marketCap":6611144229},{"date":"2024-12-20","current":-6.996616,"twenty":-14.515749,"median":-11.205913,"eighty":-9.802907,"marketCap":5200430909},{"date":"2024-12-27","current":-7.475343,"twenty":-14.417732,"median":-11.110343,"eighty":-9.696726,"marketCap":5556258153},{"date":"2025-01-03","current":-7.255044,"twenty":-14.310948,"median":-11.04193,"eighty":-9.447445,"marketCap":5392514642},{"date":"2025-01-10","current":-7.941361,"twenty":-13.904149,"median":-10.968115,"eighty":-9.277996,"marketCap":5902638655},{"date":"2025-01-17","current":-7.360957,"twenty":-13.814237,"median":-10.857866,"eighty":-8.901726,"marketCap":5471237484},{"date":"2025-01-24","current":-11.616544,"twenty":-13.589703,"median":-10.821474,"eighty":-8.900296,"marketCap":8634321255},{"date":"2025-01-31","current":-12.114335,"twenty":-13.372582,"median":-10.83967,"eighty":-9.084572,"marketCap":9004318610},{"date":"2025-02-07","current":-13.766579,"twenty":-13.580172,"median":-10.892118,"eighty":-9.145072,"marketCap":10232394938},{"date":"2025-02-14","current":-17.740436,"twenty":-14.414343,"median":-10.977749,"eighty":-9.176796,"marketCap":13186075951},{"date":"2025-02-21","current":-16.251299,"twenty":-14.626169,"median":-11.042495,"eighty":-9.240319,"marketCap":12079232799},{"date":"2025-02-28","current":-13.492832,"twenty":-14.626169,"median":-11.116634,"eighty":-9.28821,"marketCap":9523362310},{"date":"2025-03-07","current":-11.921515,"twenty":-14.53127,"median":-11.296894,"eighty":-9.306641,"marketCap":8414312522},{"date":"2025-03-14","current":-10.287979,"twenty":-14.446116,"median":-11.151149,"eighty":-9.381512,"marketCap":7261348495},{"date":"2025-03-21","current":-11.72144,"twenty":-14.421968,"median":-11.296894,"eighty":-9.48981,"marketCap":8273098108},{"date":"2025-03-28","current":-12.680334,"twenty":-14.416037,"median":-11.432255,"eighty":-9.599308,"marketCap":8949894019},{"date":"2025-04-04","current":-11.318823,"twenty":-14.402423,"median":-11.47731,"eighty":-9.665899,"marketCap":7988927284},{"date":"2025-04-11","current":-9.87731,"twenty":-14.338727,"median":-11.360942,"eighty":-9.665899,"marketCap":6971494050},{"date":"2025-04-17","current":-10.017048,"twenty":-14.29676,"median":-11.318823,"eighty":-9.696726,"marketCap":7070122782},{"date":"2025-04-25","current":-13.115812,"twenty":-14.136074,"median":-11.289749,"eighty":-9.724555,"marketCap":9257258170},{"date":"2025-05-02","current":-12.711306,"twenty":-13.868184,"median":-11.360942,"eighty":-9.734831,"marketCap":8971753946},{"date":"2025-05-09","current":-15.922428,"twenty":-14.16984,"median":-11.47731,"eighty":-9.782784,"marketCap":11290641498}],"updateTime":1746929972457}}}